StonvexLoading…
StonvexStonvexStonvexCore line items from DRS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $846.00M | $3.65B | $2.59B | $1.63B |
Operating Income | $77.00M | $348.00M | $222.00M | $129.00M |
Net Income | $62.00M | $278.00M | $176.00M | $104.00M |
EPS (Diluted) | $0.23 | $1.03 | $0.65 | $0.39 |
Total Assets | $4.21B | $4.49B | $4.25B | $4.08B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $328.00M | $647.00M | $309.00M | $278.00M |
Free Cash Flow OCF − CapEx | $-96.00M | $227.00M | $-149.00M | $-226.00M |
Shares Outstanding | 265.97M | 265.82M | 266.10M | 266.19M |